Clinical treatment guidelines

Clinical guidelines for the treatment and management of migraine aim to aid clinicians and thereby improve care. Variations in the weight given to different empirical data and their consequences for clinical practice influence the guidelines, and consequently, at the moment, there is not universal consensus for all parts of the treatment of migraine ^{[Eigenbrodt et al. 2021; Steiner et al. 2019; Worthington et al. 2013]}.

References:
Eigenbrodt AK, Ashina H, Khan S et al. Diagnosis and management of migraine in ten steps. Nat Rev Neurol. 2021; 17: 501-514.

Steiner TJ, Jensen R, Katsarava Z. Aids to management of headache disorders in primary care (2nd edition). J Headache Pain. 2019; 20(1):57.

Worthington I, Pringsheim T, Gawel MJ, et al. Canadian Headache Society Guideline: acute drug therapy for migraine headache. Can J Neurol Sci 2013; 40 (5 Suppl 3): S1–S80.

Other references used on slide:
National Institute for Health and Care Excellence (NICE) website. Developing NICE guidelines: the manual. Accessed September 2022

Murad MH. Clinical practice guidelines: A primer on development and dissemination. Mayo Clin Proc. 2017: 92(3):423-433.